Fentanilo transdérmico en el tratamiento de la fibromialgia

Rubio, José Luis Callejas; Moyano, Antonio Fernández; Hidalgo, Dolores; Palmero, César Palmero

doi:10.1016/s0025-7753(03)73702-6

Cited by 3 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, in a study of about 7 million members of a German statutory health insurance company, strong opioids were prescribed for 11% with FMS [35]. The German guideline search of literature identified only one case series wherein the majority of patients worsened or discontinued therapy because of side effects [36]. Opioid use in FMS was associated with negative health-related measures in a prospective cohort study of a Canadian interdisciplinary pain center [37].…”

Section: Reviewmentioning

confidence: 99%

Review of pharmacological therapies in fibromyalgia syndrome

et al. 2014

View full text Add to dashboard Cite

This review addresses the current status of drug therapy for the management of fibromyalgia syndrome (FMS) and is based on interdisciplinary FMS management guidelines, meta-analyses of drug trial data, and observational studies. In the absence of a single gold-standard medication, patients are treated with a variety of drugs from different categories, often with limited evidence. Drug therapy is not mandatory for the management of FMS. Pregabalin, duloxetine, milnacipran, and amitriptyline are the current first-line prescribed agents but have had a mostly modest effect. With only a minority of patients expected to experience substantial benefit, most will discontinue therapy because of either a lack of efficacy or tolerability problems. Many drug treatments have undergone limited study and have had negative results. It is unlikely that these failed pilot trials will undergo future study. However, medications, though imperfect, will continue to be a component of treatment strategy for these patients. Both the potential for medication therapy to relieve symptoms and the potential to cause harm should be carefully considered in their administration.

show abstract

Section: Reviewmentioning

confidence: 99%